.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
CULTA is stocked at 79 licensed dispensaries across Maryland, with the deepest coverage in Baltimore, Silver Spring, Annapolis, Frederick, and Hagerstown. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, CULTA’s mix concentrated in Pre-Roll at 48.11% share (ranked 9th in Maryland Pre-Roll), while Flower fell to 30.70% share; these positions coincide with Pre-Roll sales declining 10.28% month over month and 8.11% year over year, versus Flower contracting 38.17% MoM and 84.51% YoY. Vapor Pens expanded to 11.27% share with a 79.46% MoM surge despite a 65.18% YoY drop, and Concentrates reached 9.86% share with 28.11% MoM and 208.15% YoY growth, as the brand’s average price fell 36.24% YoY to $19.22. The pattern implies CULTA is reallocating demand from collapsing Flower into faster-moving Vapor Pens and Concentrates while defending a mid-pack Pre-Roll position, signaling a pivot toward value-accessible inhalables anchored by Pre-Roll where rank 9 sets the competitive ceiling.
The simultaneous 79.46% MoM rebound in Vapor Pens and 28.11% MoM lift in Concentrates, alongside a 10.28% MoM dip in Pre-Roll and a 38.17% MoM retreat in Flower, indicates consumer trade-down and format switching concentrated in inhalable convenience and potency tiers as average prices compress 36.24% YoY. With Concentrates posting 208.15% YoY growth and Pre-Roll holding the largest share at 48.11% despite YoY decline, the mix shift implies CULTA’s near-term positioning will benefit from prioritizing differentiated Pre-Roll and Concentrates assortments while using Vapor Pens as the recovery lever, because Flower’s 84.51% YoY contraction and 30.70% share erosion reduce its role as a volume anchor.
Competitive Landscape
CULTA sits at rank 9 in MD Pre-Roll for October 2026, unchanged from rank 9 in October 2025, after climbing 4 positions from rank 13 in July 2026 and retreating from a peak rank of 7 in June 2026; in contrast, SunMed holds rank 1 with a 10.6% year-over-year sales increase and Strane improved its position from rank 5 to rank 4 alongside a 91.2% year-over-year sales increase, indicating CULTA’s flat year-over-year rank at 9 amid mid-year volatility implies stability without momentum relative to faster-rising peers.
Notable Products
CULTA leans on very recent launches in October 2026, with 118 new products generating 54.3% of sales, including Titan OG Pre-Roll 2-Pack (1g) among the top items. That means over half of CULTA’s revenue comes from products first sold in the last six months, so most of its sales ride on new releases.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
